Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bayoubuckson Jul 16, 2014 3:18pm
208 Views
Post# 22752256

RE:RE:Stock options

RE:RE:Stock optionsMoney, have you run the numbers on the TLC-2000 rollout?  At a $99 mo. and $500 thereafter lease, it's going to take a looooooooong time to have positive cash flow.  If the cost to manufacture is the same as the TLC-1000, $10,000, it will take 23 months just to break even.  If you're in this stock for the laser play, you might want to re-think you're decision.  Check the numbers yourself.  Cancer, yes, laser, no.  According to Roger, in August 2013, the 2000 would be out Q1.  Now it's Q4, with no explanation.  Take it for what it's worth.
Bullboard Posts